Centre De Pharmacologie Clinique Appliquee A La Dermatologie
- Address
- lock Available on a paid plan
Skin and Connective Tissue Diseases
The Centre De Pharmacologie Clinique Appliquee A La Dermatologie in Nice is conducting clinical research focused on skin and connective tissue diseases. The studies are centered on improving care for corticosteroid-sensitive dermatosis and helping address prevention of anticancer therapy adverse reactions, with an emphasis on evaluating new topical treatments and their clinical benefits.
- Research on corticosteroid-sensitive dermatosis and other dermatologic conditions
- Studies aimed at preventing adverse reactions linked to anticancer treatment
- Evaluation of topical therapies for skin-related conditions
This site’s work in clinical pharmacology and dermatology supports testing the effectiveness and tolerability of new skin treatments in healthy volunteers and patients.
Topical Treatment Evaluation
Clinical trials at this research facility are also examining how new topical formulations perform on the skin, with attention to local tolerance and the body’s response to treatment. The goal is to better understand whether these products offer safe and effective options for managing inflammatory skin disorders.
- Assessment of skin tolerance for new dermatologic products
- Testing of treatment effectiveness for skin applications
- Support for development of improved topical therapies
With a small but focused portfolio of studies, the site contributes to research that helps refine skin treatment options and advance practical solutions in dermatology.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Substipharm2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre De Pharmacologie Clinique Appliquee A La Dermatologie
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Plaque Psoriasis | Bristol-Myers Squibb Services Unlimited Company | Phase III | Not Recruiting | Dec 2019 | Jul 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Deucravacitinib | 1 | Unknown | 2019-12-12 | 2019-12-12 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.